FORM OF COMMON STOCK PURCHASE WARRANT entremed, inc.Common Stock Purchase Warrant • March 6th, 2013 • Entremed Inc • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September ___, 2013 (the “Initial Exercise Date”) and on or prior to the close of business on the third anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from EntreMed, Inc., a Delaware corporation (the “Company”), up to _____ shares (subject to adjustments as provided below) (the “Warrant Shares”) of Common Stock.
December 11, 2012Investment Banking Agreement • March 6th, 2013 • Entremed Inc • Biological products, (no disgnostic substances) • California
We are pleased that EntreMed, Inc. (including its affiliates, the “Company”) has chosen to engage Burrill LLC (“Burrill”) to act as its investment banker for a capital raising (a “Financing”). This letter agreement (the “Agreement”) contains the terms pursuant to which the Company agrees to engage Burrill and Burrill agrees to provide services to the Company (the “Engagement”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 6th, 2013 • Entremed Inc • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made as of March 1, 2013, between EntreMed, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
FORM OF COMMON STOCK PURCHASE WARRANT entremed, inc.Common Stock Purchase Warrant • March 6th, 2013 • Entremed Inc • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, BURRILL SECURITIES LLC (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September ___, 2013 (the “Initial Exercise Date”) and on or prior to October 9, 2017 (the “Termination Date”) but not thereafter, to subscribe for and purchase from EntreMed, Inc., a Delaware corporation (the “Company”), up to 61,250 shares (subject to adjustments as provided below) (the “Warrant Shares”) of Common Stock. This Warrant is issued by the Company as of the date hereof pursuant to Section 3(a) of the Engagement Agreement, dated as of December 11, 2012, between the Company and Burrill LLC.
